Loading...

BioELife Corp.

LITH•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(29900.00%)
U.S. Market is Open • 14:15

BioELife Corp. (LITH) Stock Overview

Explore BioELife Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8K
P/E Ratio-0.00
EPS (TTM)$-0.22
ROE1.70%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

LITH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioELife Corp. (LITH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 78.84, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 2.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
29900.00%
5-Day Change
200.000%
1-Month Change
200.000%
3-Month Change
29900.00%
6-Month Change
200.000%
Year-to-Date (YTD) Change
200.00%
1-Year Change
200.000%
3-Year Change
N/A
5-Year Change
-99.91%
All-Time (Max) Change
-99.96%

Contact Information

https://www.bioelife.com
702-866-2500
12340 Seal Beach Boulevard, Seal Beach, CA, 90740

Company Facts

1 Employees
IPO DateAug 7, 2009
CountryUS
Actively Trading

Frequently Asked Questions